Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy. Old myocardial infarction is less common cause of MSVT in Japan, and the majority (about 2/3) of MSVT is unrelated to coronary artery disease but, the mechanism shared a common mechanism: reentry with an excitable gap as others. The reentrant mechanism was supported from the inducibility, the terminability of VT by electrical stimulation, and by the ability to entrain with rapid pacing. In MSVT associated with underlying heart diseases, diseased myocardium showed low amplitude and fragmented electrograms and the area was considered to participate as the central common pathway of reentrant circuit. The area of slow pathway showed a decremental conduction or all-ornothing conductive property. The width of the excitable gap seemed to be determined by the maximal conductive frequency but not by the duration of action potential: effective refractory period. As to the drug efficacy, there was no baseline characteristics in predicting the efficacy. However, the significant narrowing of the width of the excitable gap was associated with the drug efficacy and VT became non-inducible after addition of the same drug. The response pattern of the excitable gap to specific drug including class III, was not predictable. Further electropharmacological studies will be warranted. (Jpn Heart J 1998; 39: 121-137) 
error way. There is no parameter which enables us to predict the efficacy of a specific drug for a specific patient. In this paper, we review MSVT in relation to the electrophysiologic study and their relation to drug efficacy based on our experiences.
MECHANISM OF MSVT
MSVT associated with coronary artery disease has been most extensively studied,1,2,9) however, in Japan, MSVT associated with coronary artery disease; actually old myocardial infarction, occupies only 1/3 and the rest (about 2/3) of MSVT is unrelated to coronary artery disease. 4, 5) Furthermore, in about 1/4, we were unable to detect an abnormality of the heart by the routine non-invasive or invasive examinations. The underlying heart diseases at our institution were shown in Table I . When MSVT was documented, the same MSVT can be induced by programmed electrical stimulation in >90%. Exception was MSVT in some non-ischemic heart disease or that which developed during antiarrhythmic therapy. Though we had diverse underlying heart diseases, we were able to demonstrate evidence which can be most well explained by a reentrant mechanism. 4) Most direct proof of reentry is to demonstrate the whole circuit on which wave fronts revolve.10) By extensive endocardial mapping, we confirmed such revolution of wave fronts but only in 4 (2.6%) among 150 patients ( Figure 1 ). During intraoperative mapping, other workers have demonstrated the reentrant circuit was suggested in up to 25% but they were incomplete ones. [11] [12] [13] [14] Most MSVT can be mapped as that which spreads radially from a focal point, as shown in Table II . For the majority of MSVT, we have to confirm the reentrant mechanism by indirect means. Of these, a clinically useful tool is to demonstrate the phenomenon of transient entrainment. 3, 4, 9) As shown in Figure 2 , the QRS complexes show intermediate but constant morphology during rapid pacing when MSVT was overdriven and the original VT resumes immediately after the cessation of rapid pacing. The constant but intermediate morphology of QRS complex is due to the fusion complex: fusion between the wave fronts from the paced site and that from the exit of VT which was accelerated to the pacing rate: constant fusion. As the paced cycle length shortens, the site of fusion of two wave fronts moves towards the exit of VT and the myocardium directly captured from the paced site will increase resulting in the QRS morphology closer to that of fully paced morphology: progressive fusion. The ability to demonstrate constant fusion is affected by the spatial relationship between the pacing site and the VT origin.9,15) The closer to the VT origin, the more difficult in demonstrating fusion complex in the surface ECG since the myocardium activated from the VT origin becomes smaller. However, when the electrogram was recorded from the exit from the presumed slow pathway of VT, or within the area of slow conduction, we can confirm that VT was really entrained though the QRS complexes show fully paced morphology.4) When VT is entrained, the local electrogram at the VT origin will be accelerated to the (Waldo et al.) pacing rate without a change in the morphology: advancement of the local electrogram without a change in morphology. When VT resumes immediately after cessation of rapid pacing, the first interval of the local electrogram will be equal to the paced cycle length. Such advancement of the local electrogram must be an underlying requirement for other criteria of transient entrainment (Table III) and we are routinely seeking if the local electrogram at the VT origin to confirm that VT is entrained or not. The relationship between the local electrogram at the exit of VT origin and the QRS morphology in the surface electrocardiogram have been well discussed by Almendral et al. 16 ) By endocardial mapping, we might be able to record diastolic potential from the site which is engaged in the active limb of the reentrant circuit. If the site is the active limb, we pace at the site and demonstrate that VT accelerates to the pacing rate without a change in the configuration of the QRS complexes: concealed entrainment. Further criteria are that the stimulus to the QRS complex interval is identical to the diastolic potential to the QRS complex of VT interval and the return cycle of the local potential is equal to the cycle length of VT. [17] [18] [19] THE ELECTROPHYSIOLOGIC PROPERTIES OF THE AREA OF SLOW CONDUCTION For the revolution of wave fronts (reentry), an area of slow conduction is essential. Histologically, surviving myocardial cells separated by interstitial fibrosis with a loose intercellular connection (gap-junction) observed at the site of "VT origin" in VT are associated with old myocardial infarction. 13, 20) The myocardial cells within such diseased tissue were found to show normal resting membrane potential, though some workers demonstrated depolarized cells. 13, [21] [22] [23] The analysis of the return cycle permits the estimation of the conductive property since the return cycle represent conduction time from the stimulus site to the exit. They observed three response patterns as the extrastimulus was given at a progressively shorter interval: flat pattern, increasing pattern and mixed pattern characterized by initially flat but followed by a increasing pattern. The increasing part of the return cycle was considered to be due to a conduction delay within the area of slow conduction which is caused when the stimulated wave front entered the reentrant circuit and met the refractory tissue.25)
However, a delay in the intervening tissue between the pacing site and the entrance to the area of slow conduction: outside of the reentrant circuit, could be partly responsible for the increasing part of the return cycle especially when extrastimuli were given at shorter coupling intervals. This delay in the interven- Figure 5 . Interruption of VT with rapid pacing. The cycle length of VT was 290 msec and interrupted at the paced cycle length of 250msec (A). On the right, fusion complexes were evident but followed by the fully paced QRS morphology. At the same time, the local electrogram at the exit in the right ventricular outflow tract (RVO) showed a change in the timing of activation and the morphological change as magnified in B. I, II, V1=surface ECG leads; HBE=His bundle area; RVA=right ventricular apex. the study was repeated using mexiletine32) and the block cycle length was again found to be prolonged significantly after mexiletine. Because mexiletine shortens the duration of the action potential,31) the change in the block cycle length must be determined by a factor other than the duration of the action potential. Actually, the effective refractory period remained unchanged at the pacing site (normal myocardium) and at the VT origin (diseased myocardium). We considered that postrepolarization refractoriness is the major determinant of the block cycle and the orthodromic block occurs as a result of uncoupling of intercellular conduction at a critical cycle length.
THE EXCITABLE GAP VS. THE ZONE OF ENTRAINMENT
From the studies mentioned above, we may be able to define the width of the excitable gap as the difference between the cycle length of VT and the shortest coupling interval of extrastimulus which terminated VT.2,25) However, the VT-terminating critical coupling interval is achieved only in limited cases. Furthermore, when an extrastimulus is given far from the reentrant circuit, the excitable gap might be overestimated because of a delay between the pacing site and the entrance to the reentrant circuit at increasing prematurity.
With rapid pacing, VT can be highly terminated and the difference between the cycle length of VT and the block cycle length at which 1:1 intercellular conduction fails will constitute the excitable gap. We defined the width of zone of entrainment as the difference between the cycle length of VT and the block cycle length and used this as the index of the width of the excitable gap, and we attempted to characterize VT and to use it in evaluating the action of antiarrhythmic agents.16.17.32) However, it is noted that the major determinant of the block cycle length is not defined by the duration of action potential, but by a failure in 1:1 cell to cell conduction.
PHARMACOLOGICAL INTERVENTIONS OF MSVT
In reentrant VT inducible with programmed stimulation, the ability to prevent the induction of VT has been used as a hallmark of drug efficacy,5-8) but the precise mechanism by which MSVT is rendered non-inducible is not known.
So far, some electrocardiographic or electrophysiologic parameters have been shown in association with drug-efficacy in reentrant VT. They include the baseline refractory period and the QT interval '33) the HV interval,", drug-induced changes in the effective refractory period, the duration of the paced QRS complex 11-3) and the change in the signal average surface electrocardiogram. 39) However, these parameters were obtained from the normal myocardium40) and and the selection of the optimal agent has to be undertaken in a trial-and-error manner. Furthermore, efficacy of the antiarrhythmic agents is limited and the overall efficacy rate is <50%5-8) and no predictor of drug-efficacy has been established so far.
The Sicilian Gambit 42) provided a new formulation in classifying antiarrhythmic agents depending on the mechanism of arrhythmia and the characteristics of the target of the drug: ion channels or receptors. For reentrant VT, they proposed a hypothesis that if VT has a narrow excitable gap, the gap might be obliterated by class III drugs by which the revolution of the wave fronts is rendered impossible.") On the other hand, if VT has a wider excitable gap, class I drugs are preferred to depress the conductivity of the reentrant pathway."' This hypothesis has not yet been addressed and our recent studies have provided some new data.
We address two issues of antiarrhythmic drug therapy: (1) if an antiarrhythmic agent acts preferentially on the diseased myocardium and (2) what is the possible mechanism by which induction of MSVT is suppressed.
PREFERENTIAL ACTION OF ANTIARRHYTHMIC AGENTS
Kay et a1.44) compared the change in the orthodromic conduction time: the time interval from the paced stimulus to the entrained local electrogram at the site of VT origin with that of the antidromic conduction time which was measured when the heart was paced during sinus rhythm. The change in the cycle length of VT was highly correlated with the change in the orthodromic conduction time but not with that of the antidromic conduction time. This result was considered to represent a preferential action of procainamide on the area of slow conduction. They treated VT associated with old myocardial infarction but a similar finding was confirmed in reentrant VT unrelated to coronary artery dis- eases.45) Alternatively, a preferential action of antiarrhythmic agents on the diseased myocardium might be demonstrated by observing the drug-induced change of the local electrical activity. [46] [47] [48] The electrogram from diseased myocardium, within the area of slow conduction at the exit, often showed fragmentation (>70 msec) with low amplitude (<0.5mV in peak to peak amplitude). 24) Procainamide was shown to prolong the duration of fragmented activity much more than the duration of the local electrogram from the normal myocardium during sinus rhythm.46,47) At relatively lower rates, mexiletine may show no effect on the diseased myocardium because of its rapid dissociation from Nachannels but a preferential action of mexiletine can be revealed at higher heart rates or during VT as shown in Figure 6 . 48) Bigger changes either in the cycle length of VT or of block cycle length defined above compared to that of the width of the QRS complex or local conduction time: from exit to a remote site, can be easily confirmed in an electrophysiologic study and from these findings, a preferential action on the diseased myocardium is confirmed in humans ( Figure 6 ). the width of the zone of entrainment at intermediate dosages of the drugs and compared then with the drug-efficacy at the final dosages. Using procainamide, disopyramide, mexiletine or cibenzoline, 18 drug tests were performed and VT was rendered noninducible in 8 tests of 8 patients. None of the basal electrophysiologic characteristics was a predictor of drug-efficacy. In this study, we evaluated the parameters of VT at the intermediate dosage. The cycle length of VT and the block cycle length were prolonged to a similar degree in the tests with efficacious drug and those with the non-efficacious drugs. However, when the width of the zone of entrainment was compared, a significant narrowing was observed only when tested with efficacious drugs and the absolute value of the width of the zone of entrainment was significantly narrower compared to the non-responders or the tests with non-efficacious drugs (Figure 8 ). The drug-induced obliteration of the width of the excitable gap was suggested to be associated with the subsequent non-inducibility when the same drug was increased at the final dose.50) Unfortunately, we are again unable to predict the drug-efficacy prior to its trial from the baseline parameters; the cycle length of VT, the block cycle length or the zone of entrainment.
The clinical implication of the last study is that if the 
